Live Breaking News & Updates on Invo Bioscience

Stay updated with breaking news from Invo bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

INVO Bioscience Surges On NAYA Acquisition Deal

Shares of INVO Bioscience, Inc. (INVO) surged on a deal to buy NAYA Biosciences in an all-stock deal. INVO is currently trading at $2.8400, up $2.3000 or 425. ....

Daniel Teper , Bioscience Inc , Invo Bioscience ,

Breaking Stock News - INVO Bioscience (NASDAQ: INVO) and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company

Breaking Stock News - INVO Bioscience (NASDAQ: INVO) and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company ....

United States , Daniel Teper , Pearl Cohen , Steve Shum , Exchange Commission , Bioscience Inc , Biosciences Inc , Securities Exchange , Glaser Weil Fink Howard Jordan Shapiro , Intravaginal Culture System , Hepatocellular Carcinoma , Multiple Myeloma , Cytovia Therapeutics , Chief Executive Officer , North America , Proposed Merger , Current Report , Merger Agreement , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Investor Ideas , Invo Bioscience , Aya Biosciences , Merger Agreement , Publicly Traded ,

INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET

/PRNewswire/ INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced. ....

United States , Steve Shum , Securities Exchange , Exchange Commission , Company Definitive Proxy Statement On Schedule , Bioscience Inc , Special Meeting , Definitive Proxy Statement , Proxy Statement , Nasdaq Marketplace Rule , Exercise Price , Notice Regarding , Proxy Materials , North America , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Invo Bioscience ,

INVO Bioscience, Inc. (NASDAQ:INVO) Q2 2023 Earnings Call Transcript

Operator: Good afternoon. And welcome, to the INVO Bioscience Second Quarter Fiscal Year 2023 Financial Results Conference Call. All participants will be in listen-only mode. ....

United States , Nuevo Leóx , Steve Shum , Elizabeth Fritz , Robert Blum , Mike Campbell , Andrea Goren , Securities Exchange , Business Development , Fertility Centers In America , Invo Bioscience Inc , Centers In Birmingham , Call Transcript August , Second Quarter Fiscal Year , Results Conference , Chief Operating , Chief Financial , Securities Act , Securities Exchange Act , Safe Harbor , Private Securities Litigation Reform Act , Chief Executive Officer , Fertility Centers , Invo Bioscience ,

INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

/PRNewswire/ INVO Bioscience, Inc. (NASDAQ: INVO), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with. ....

United States , Bioscience Inc , Webcast Information , Investor Relations , North America , Invo Bioscience , Health Care Amp Hospitals , Medical Pharmaceuticals , Medical Equipment , Conference Call Announcements ,